Somnomed finds UK distribution partner
Tuesday, 08 July, 2008
Somnomed [ASX: SOM] has appointed Intus Healthcare as the company's distribution partner for the UK market.
Intus will distribute Somnomed's dental Mandibular Advancement Splint (MAS) device for sleep apnea and snoring therapy device to the market.
The UK is generally considered to be one of the most important sleep therapy markets in Europe.
Intus is a major supplier of sleep therapy products, and is headquartered on the outskirts of London.
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...
Global study finds 250 genes linked to OCD
Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
